PLSE PULSE BIOSCIENCES, INC.
Price Chart
Executive Summary
Pulse Biosciences announced it will redeem the remaining 200% Warrants (exercise price $11.00) from its July 2024 rights offering, with a redemption deadline of July 13, 2026. The stock has met the VWAP condition ($25.17 average over 20 consecutive days) to trigger the redemption. The company has already received $63.7M in gross proceeds from prior warrant redemptions and could receive up to an additional $2.1M if all remaining warrants are exercised before the deadline.
Actionable Insight
The warrant redemption forces holders to either exercise at $11.00/share (a ~56% discount to the $25.17 VWAP) or receive $0.01 per warrant. Expect near-term dilution as most warrants will be exercised, adding ~$2.1M in cash. The stock's strong performance (VWAP >$22 for 20 days) signals market confidence in the company's nano-PFA technology and atrial fibrillation pipeline. Monitor for any secondary offering or capital deployment plans post-redemption.
Key Facts
- Company delivered irrevocable notice to redeem remaining 200% Warrants (CUSIP 74587B143) issued in July 2024 rights offering
- Redemption deadline: 5:00 p.m. ET on July 13, 2026
- Exercise price: $11.00 per share; redemption price: $0.01 per warrant share
- VWAP condition met: average VWAP of $25.17 over 20 consecutive trading days preceding June 10, 2026
- Aggregate gross proceeds from rights offering: $60 million
- Additional gross proceeds from warrant redemptions to date: $63.7 million
- Potential additional proceeds if remaining warrants exercised: $2.1 million
- First tranche (150% Warrants) redeemed in February 2025; none outstanding
Financial Impact
Up to $2.1M additional cash from warrant exercises; $63.7M already received from prior redemptions; total rights offering + warrant proceeds ~$125.8M
Risk Factors
- Dilution from warrant exercises increases share count
- Potential stock price pressure as warrant holders sell exercised shares
- No guarantee remaining warrants will be exercised before deadline
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-020085 |
| Exhibit: ex_973581.htm | 0001437749-26-020085 |
| Document: 0001437749-26-020085-index-headers.html | 0001437749-26-020085 |
| Document: 0001437749-26-020085-index.html | 0001437749-26-020085 |
| Document: 0001437749-26-020085.txt | 0001437749-26-020085 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
2d ago
|
Institutional Cluster
| $26.89 awaiting T+5 | awaiting T+5 | — | $24.37 (−9.37%) |
|
Jun 10, 2026
4d ago
|
8-K
| $25.79 awaiting T+5 | awaiting T+5 | — | $24.37 (−5.51%) |
|
May 15, 2026
4w ago
|
Insider Cluster
| $25.61 $26.00 | ▲ +1.52% | ▼ −0.10% | $24.37 (−4.84%) |
|
May 11, 2026
5w ago
|
Insider Cluster
| $19.08 $25.61 | ▲ +34.22% | ▲ +34.31% | $24.37 (+27.73%) |
|
May 11, 2026
5w ago
|
Insider Cluster
| $19.08 $25.61 | ▲ +34.22% | ▲ +34.31% | $24.37 (+27.73%) |
|
May 6, 2026
5w ago
|
8-K
| $19.21 $23.30 | ▲ +21.29% | ▲ +20.16% | $24.37 (+26.86%) |
|
May 4, 2026
5w ago
|
8-K
| $20.03 $19.08 | ▼ −4.74% | ▼ −7.68% | $24.37 (+21.67%) |
|
Apr 27, 2026
6w ago
|
8-K
| $22.65 $20.03 | ▼ −11.57% | ▼ −11.97% | $24.37 (+7.59%) |
|
Apr 16, 2026
8w ago
|
8-K
| $20.51 $24.25 | ▲ +18.23% | ▲ +17.25% | $24.37 (+18.82%) |
|
Apr 9, 2026
9w ago
|
8-K
| $19.25 $20.51 | ▲ +6.55% | ▲ +3.36% | $24.37 (+26.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access